Fluid delivery methods
US-2024408593-A1 · Dec 12, 2024 · US
US2017053060A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2017053060-A1 |
| Application number | US-201515118817-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jan 9, 2015 |
| Priority date | Feb 18, 2014 |
| Publication date | Feb 23, 2017 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed is a method for predicting cancer prognosis, comprising: forming gene pairs by using a plurality of genes to be tested; determining clusters for the formed gene pairs through a clustering method; calculating a distribution of each gene pair based on the determined cluster; and selecting reference gene pairs for determining a class based on the calculated distribution.
Opening claim text (preview).
What is claimed is: 1 . A method for predicting cancer prognosis, the method comprising: forming gene pairs by using a plurality of genes to be tested; determining clusters for the formed gene pairs through a clustering method; calculating a distribution of each gene pair based on the determined cluster; and selecting reference gene pairs for determining a class based on the calculated distribution. 2 . The method for predicting the cancer prognosis of claim 1 , the method further comprising: selecting a plurality of genes to be tested in microarray data according to a predetermined reference, before forming the gene pairs. 3 . The method for predicting the cancer prognosis of claim 2 , wherein in the selection of the genes, the plurality of genes to be tested is selected by using at least one of Relief-A and Symmetrical Uncertainty algorithms. 4 . The method for predicting the cancer prognosis of claim 1 , the method further comprising: receiving a correct answer class for the plurality of genes to be tested, before forming the gene pairs. 5 . The method for predicting the cancer prognosis of claim 4 , wherein in the determining of the clusters for the formed gene pairs, the clusters are determined by clustering for the gene pairs which belong to the same correct answer class. 6 . The method for predicting the cancer prognosis of claim 1 , wherein in the calculating of the distribution of each gene pair, the distribution is calculated by a sum of Euclidean distances for average values of the determined clusters for the gene pairs. 7 . The method for predicting the cancer prognosis of claim 1 , the method further comprising: receiving expression levels for the gene pairs of the test sample, after selecting the reference gene pairs for determining the class; and predicting a class for each gene pair of the test sample by projecting the expression levels for the gene pairs of the test sample to a 2D image for the reference gene pairs. 8 . The method for predicting the cancer prognosis of claim 7 , wherein in the predicting of the class for each gene pair of the test sample, the class for each gene pair is predicted based on the expression levels for the gene pairs of the test sample projected to the 2D image and Euclidean distances between the plurality of classes. 9 . The method for predicting the cancer prognosis of claim 8 , wherein in the predicting of the class for each gene pair of the test sample, the class for each gene pair of the test sample is predicted as a class having a relatively smaller Euclidean distance. 10 . The method for predicting the cancer prognosis of claim 8 , wherein in the predicting of the class for each gene pair of the test sample, when the Euclidean distances between the gene pairs of the test sample and the plurality of classes are the same as each other, the class for each gene pair is predicted based on a sum of the Euclidean distances between the gene pairs of the test sample and all clusters which belong to each of the plurality of classes. 11 . The method for predicting the cancer prognosis of claim 10 , wherein in the predicting of the class for each gene pair of the test sample, the class for each gene pair of the test sample is predicted as a class having a relatively smaller sum of the Euclidean distances. 12 . The method for predicting the cancer prognosis of claim 7 , the method further comprising: determining a final class of the test sample, after predicting the class for each gene pair of the test sample. 13 . The method for predicting the cancer prognosis of claim 12 , wherein in the determining of the final class of the test sample, the final class is determined as the most predicted class among the predicted classes for each gene pair of the test sample.
using probe arrays or probe chips (C12Q1/6874 takes precedence) · CPC title
Physics · mapped topic
for cancer (immunoassay for cancer G01N33/575) · CPC title
Prognosis of disease development · CPC title
Expression markers · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.